The FDA's Center for Devices and Radiological Health on Aug. 30 issued draft guidance on the performance criteria and testing methodologies devicemakers can use to support 510(k) submissions for facet screw systems.
The Latest
A surgeon from Atlanta-based Resurgens Orthopaedics was cleared of allegations of negligence after a patient contracted a postsurgery infection that caused him to lose part of his foot, according to Law.com.
One month after Bioventus announced its plan to acquire spine devicemaker Misonix in a $518 million deal, the orthobiologics company is lining up a reported $500 million purchase of Israeli medtech company Cartiheal.
Global medical technology company Smith+Nephew's OXINIUM technology has shown strong performance measures in hip and knee arthroplasties.
Zimmer Biomet and medical data company Canary Medical received FDA approval to market the tibial extension for Persona IQ, the first smart implant for total knee replacement, according to an Aug. 30 news release.
The value of the minimally invasive spinal market decreased in 2020 because of the COVID-19 pandemic, but three companies still control the lion's share of the market, according to iData Research, a global consulting and market research firm.
Weiss Memorial Hospital has appointed Thomas McNally, MD, medical director of the Spine Center at the Chicago Center for Orthopedics and Robotic-Assisted Surgery.
A Florida sports medicine specialist and practice founder was honored by his community, News4Jax reported Aug. 27.
Leadership changes are rife among orthopedic practices, with 13 groups announcing new CEOs in the past 20 months:
From lessons learned after bad investments to the most promising areas of regenerative medicine, here are three surgeon quotes that caught the attention of Becker's readers this week: